{"nctId":"NCT00586625","briefTitle":"Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers","startDateStruct":{"date":"2007-10"},"conditions":["Allergic Conjunctivitis"],"count":861,"armGroups":[{"label":"Bepreve","type":"EXPERIMENTAL","interventionNames":["Drug: Bepreve"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Bepreve","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects must be at least 3 years of age, and have ocular health within normal limits\n\nExclusion Criteria:\n\n* No active ocular disease","healthyVolunteers":true,"sex":"ALL","minimumAge":"3 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Ocular Comfort","description":"A 4-step grading scale with half unit (1-step) increments allowed:\n\n0=Comfortable;discomfort absent; 1.0=Generally comfortable; mild discomfort; 2.0=Some discomfort but tolerable; moderate comfort; 3.0=Severely uncomfortable or intolerable","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.13","spread":"0.35"},{"groupId":"OG001","value":"0.07","spread":"0.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.06","spread":"0.25"},{"groupId":"OG001","value":"0.02","spread":"0.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1","spread":"0.33"},{"groupId":"OG001","value":"0.06","spread":"0.23"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05","spread":"0.22"},{"groupId":"OG001","value":"0.04","spread":"0.17"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":575},"commonTop":["Mild Taste"]}}}